The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
This was the right decision giving me the broadest overview, confidence, tools, network and support that is fundamental to feel right in my daily decision process and to keep on learning.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
Excellent professional gathering, perfect collection of topics and very up-to-date insight.
Ludovic Urgeghe
University of Mons, Belgium
The experts, the specific content and the informal setting will improve you as a professional.
Brechtje Vreenegoor
Radboud Universteit, Netherlands
ASTP's conference helped us to network with decision-makers in the technology transfer industry and provides a great platform to discuss future innovation in this sector.
Christopher Römer
Inventtory, Germany
A must-do for any staff involved in technology transfer and start-up creation.
Frederic Ratel
Institute of Chemical Research of Catalonia, Spain
Join our newsletter and get the latest news